La Universidad Maimónides es una universidad privada situada en Buenos Aires, Argentina. Fue fundada por la Fundación Científica Felipe Fiorellino el 20 de junio de 1990. Su funcionamiento fue autorizado por el Ministerio de Educación de la Nación Argentina el 20 de junio del mismo año por la Resolución n.º 1097/90.

During the past decade, Maimonides University conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maimonides University" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Maimonides University" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Camila Velo Etcheverry" with 1 trials sponsored and "Mariel Viviana Gómez" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maimonides University" #1 collaborator was "Maimonides University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Maimonides University" are "Alzheimer Disease" (2 trials), "Cardiovascular Disease" (2 trials), "Achilles Tendinopathy" (1 trials), "Alzheimer's Disease" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Maimonides University" in a lesser frequency.

Most popular intervention types in "Maimonides University" are "Drug" (5 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Gantenerumab" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Aussie" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maimonides University" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Maimonides University". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Maimonides University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Maimonides University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".